Revolution Medicines Stock: RASONQUE FDA Approval Zoldonrasib PDAC Expansion (NASDAQ:RVMD)
· seekingalpha.com
Revolution Medicines (RVMD) gets FDA approval for RASONQUE and advances zoldonrasib Phase 3 trials—see upside, cash runway and key risks.
This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace. If you like what you ...